Bionomics Ltd Adr Stock Net Asset
| BNOX Stock | USD 0.28 0.01 3.45% |
Bionomics Ltd ADR fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Stock. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics stock.
Bionomics | Net Asset |
Bionomics Ltd ADR Company Net Asset Analysis
Bionomics' Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Bionomics Net Asset | 27.65 M |
Most of Bionomics' fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bionomics Net Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Bionomics is extremely important. It helps to project a fair market value of Bionomics Stock properly, considering its historical fundamentals such as Net Asset. Since Bionomics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bionomics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bionomics' interrelated accounts and indicators.
Click cells to compare fundamentals
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Bionomics Total Assets
Total Assets |
|
Based on the recorded statements, Bionomics Ltd ADR has a Net Asset of 27.65 M. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The net asset for all United States stocks is notably lower than that of the firm.
Bionomics Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bionomics' direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bionomics could also be used in its relative valuation, which is a method of valuing Bionomics by comparing valuation metrics of similar companies.Bionomics is currently under evaluation in net asset category among its peers.
Bionomics Institutional Holders
Institutional Holdings refers to the ownership stake in Bionomics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bionomics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bionomics' value.| Shares | Armistice Capital, Llc | 2024-09-30 | 1.6 M | Xtx Topco Ltd | 2024-09-30 | 0.0 | Point72 Asset Management, L.p. | 2024-09-30 | 316 K | Ubs Group Ag | 2024-06-30 | 34.9 K | Two Sigma Securities, Llc | 2024-06-30 | 26 K | Beacon Pointe Advisors, Llc | 2024-06-30 | 10 K | Rhumbline Advisers | 2024-06-30 | 2.2 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.6 K | Aspire Private Capital, Llc | 2024-09-30 | 200 | Jpmorgan Chase & Co | 2024-06-30 | 1.0 | Two Sigma Investments Llc | 2024-09-30 | 0.0 |
Bionomics Fundamentals
| Return On Equity | -0.78 | ||||
| Return On Asset | -0.4 | ||||
| Operating Margin | 89.10 % | ||||
| Current Valuation | (2.08 M) | ||||
| Shares Outstanding | 19.53 M | ||||
| Shares Owned By Insiders | 33.91 % | ||||
| Shares Owned By Institutions | 16.22 % | ||||
| Number Of Shares Shorted | 190.27 K | ||||
| Price To Book | 0.34 X | ||||
| Price To Sales | 386.72 X | ||||
| Revenue | 20 K | ||||
| Gross Profit | (18.96 M) | ||||
| EBITDA | (9.84 M) | ||||
| Net Income | (15.49 M) | ||||
| Cash And Equivalents | 33.56 M | ||||
| Cash Per Share | 4.46 X | ||||
| Total Debt | 239.62 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 12.46 X | ||||
| Book Value Per Share | 1.32 X | ||||
| Cash Flow From Operations | (9.62 M) | ||||
| Short Ratio | 0.13 X | ||||
| Earnings Per Share | (1.19) X | ||||
| Target Price | 15.37 | ||||
| Beta | -0.069 | ||||
| Market Capitalization | 5.75 M | ||||
| Total Asset | 27.65 M | ||||
| Retained Earnings | (177.98 M) | ||||
| Working Capital | 9.36 M | ||||
| Net Asset | 27.65 M |
About Bionomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bionomics Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bionomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bionomics Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bionomics Stock Analysis
When running Bionomics' price analysis, check to measure Bionomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bionomics is operating at the current time. Most of Bionomics' value examination focuses on studying past and present price action to predict the probability of Bionomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bionomics' price. Additionally, you may evaluate how the addition of Bionomics to your portfolios can decrease your overall portfolio volatility.